Clinical trial
Rapid Evaluation of Cocaine Pharmacotherapies (Amantadine)
NCT00000301 is registered in ClinicalTrials.gov with University of California, Los Angeles as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Rapid Evaluation of Cocaine Pharmacotherapies (Amantadine)
- Lead sponsor
- University of California, Los Angeles
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- March 31, 1996
- Completion date
- Not reported
- Enrollment
- 0
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.